Skip to main content

Day: May 3, 2021

InterCure Opens in Jerusalem the First “LEMONNADE” Branded Pharmacy

This is the first branch under the “LEMONNADE” brand (from the Cookies family) outside of North America LEMONNADE Jerusalem is another flagship branch in InterCure’s leading, medical cannabis focused, pharmacy chain ‘Givol‘ TORONTO and HERZLIYA, Israel, May 03, 2021 (GLOBE NEWSWIRE) — InterCure Ltd. (TSX: INCR.U, TASE: INCR) (dba Canndoc) (“InterCure” or the “Company”) announced today the opening of the first “LEMONNADE” branch in Jerusalem as part of the “Givol” pharmacy chain. The Pharmacy has officially begun operating after received its cannabis dispensing license from the Israeli Medical Cannabis Agency (IMCA) on April 27, 2021. This is the first branch under the “LEMONNADE” brand (from the Cookies family) outside of North America to begin operations. The branch will operate and provide services...

Continue reading

CytoDyn to Hold Webcast on May 5 to Provide Update on Multiple Initiatives

VANCOUVER, Washington, May 03, 2021 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman and Chief Medical Officer and Chris Recknor, M.D., Chief Operating Officer will host an investment community webcast on Wednesday, May 5, 2021. Management will provide a full update to its stockholders on Company priorities, including recent COVID-19 initiatives and additional information concerning its active trials in COVID-19, NASH and cancer. Management will dedicate approximately 60 minutes to address questions submitted online by analysts and investors. Date:...

Continue reading

Just In Time For Mother’s Day, OpenTable Reveals its 2021 List of the 100 Best Brunch Restaurants in America

Survey Shows One Third of Americans Haven’t Had an Extended Family Gathering in Over a Year; New List Helps Diners Navigate the Best Brunch Spots to Reunite and Celebrate with Loved Ones SAN FRANCISCO, May 03, 2021 (GLOBE NEWSWIRE) — OpenTable, the world’s leading provider of online restaurant reservations and part of Booking Holdings Inc. (NASDAQ: BKNG), today released its annual list of the 100 Best Brunch Restaurants in America for 2021. As restaurant restrictions ease in the U.S, a recent OpenTable survey* shows 33% of Americans haven’t had an extended family gathering in more than a year, and OpenTable data shows Mother’s Day reservations are up 64% compared to 2019 (pre-pandemic levels) – a clear sign families are eager to reunite and celebrate with their loved ones this Mother’s Day. “This Mother’s Day...

Continue reading

Data from 10 Patients with Stage Four Cancer Treated with Leronlimab for Nearly One Year Will Serve as Basis for Pre-Breakthrough Therapy Designation Meeting with FDA

VANCOUVER, Washington, May 03, 2021 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (Vyrologix or PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today it is preparing a request for a pre-Breakthrough Therapy designation (BTD) meeting ahead of preparing a Phase 3 clinical trial protocol for 22 solid tumor cancer indications. The Company is extremely encouraged about the prospects of a Phase 3 trial and BTD based on preliminary indications of patients in the Company’s current Phase 2 basket trial, compassionate use study and a patient treated under an eIND, which may support a smaller trial. Scott Kelly, M.D., CytoDyn’s Chief Medical Officer, stated, “We are very encouraged by leronlimab’s potential...

Continue reading

Influenza Medication Market Forecast [2019-2026] | Size Is Projected to Reach USD 993.7 Million by 2026, Exhibiting a CAGR of 2.2%

Key Players Covered in the Influenza Medication Market are Alvogen, Amneal Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Seqirus (CSL), Genentech, Inc., Macleods Pharmaceuticals Ltd., Zydus Pharmaceuticals, Inc. (Zydus Cadila), Lupin Limited, BIOCRYST PHARMACEUTICALS, INC., Shionogi & Co., Ltd. Pune, India, May 03, 2021 (GLOBE NEWSWIRE) — The global “influenza medication market” size is projected to reach USD 993.7 million by 2026, exhibiting a CAGR of 2.2% during the forecast period. Increasing global burden of influenza will be one of the central forces driving the growth of this market. Influenza, or the flu, is a virus that infects the human respiratory system, that is, the throat, lungs, and nose. Usually, the infection subsides on its own, but sometimes it can turn severe and even prove...

Continue reading

WSI Selects Manhattan Active® Warehouse Management to Offer Advanced Commerce Services

ATLANTA, May 03, 2021 (GLOBE NEWSWIRE) — Manhattan Associates Inc. (NASDAQ: MANH) today announced that WSI, one of the nation’s leading third-party logistics (3PL) providers, has selected Manhattan Active® Warehouse Management to better facilitate operations and expand its logistics services nationwide. From planning to execution, WSI delivers complete logistics support and boasts a coast-to-coast network with a global reach. Historically, its business has been focused on the industrial and chemical space, but amid shifting market trends, the Wisconsin-based provider decided to expand its ecommerce services. To make this pivot, WSI required a warehouse management system (WMS) purpose built for connected commerce with the flexibility and scalability to adapt to future market changes. Most importantly, WSI needed a forward-thinking...

Continue reading

GSA Awards Hill International Three Contracts to Manage Office Modernizations, Renovations, and Consolidations in Columbus, OH, Woodlawn, MD, and Indianapolis, IN

PHILADELPHIA, Pa. and COLUMBUS, Ohio, May 03, 2021 (GLOBE NEWSWIRE) — Hill International (NYSE:HIL), the global leader in managing construction risk, announced today it was awarded three contracts by the General Services Administration (GSA) to manage the U.S. Bankruptcy Court (USBC) consolidation into the John W. Bricker Building in Columbus, OH; Phase 2 of Centers for Medicare and Medicaid Services (CMS) Headquarters Consolidation in Woodlawn, MD; and the renovation and repair of the roof and façade system for the Bean Federal Center in Indianapolis, IN. The USBC project will allow the Court to leave its current 51,000 SF leased space in Columbus, OH, for 26,000 SF of newly renovated and modernized offices in the John W. Bricker Federal Building, located directly across the street from the USBC’s current space. Work will involve...

Continue reading

CareCloud Promotes Leaders within its Operations Team to Support Another Record Year of Growth

SOMERSET, N.J., May 03, 2021 (GLOBE NEWSWIRE) — CareCloud, Inc. (Nasdaq: MTBC) (Nasdaq: MTBCP), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the promotion of two leaders within its management team: Loraine Goetsch to Division President and SVP of Integrations, and Steve Link to Senior Vice President of Client Operations. Goetsch and Link are working to support CareCloud’s ongoing scalability by enhancing and optimizing critical aspects such as operational integration and functional service delivery. “2020 was a record year of growth for CareCloud, formerly MTBC, and we’re pleased to announce the promotion of these talented individuals, each with a deep understanding of the healthcare industry,” said Hadi Chaudhry, CEO and President, CareCloud. “Together,...

Continue reading

Dyadic to Present at Upcoming Events

JUPITER, Fla., May 03, 2021 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced that the Company will participate in the following upcoming events: KOL Fireside Chat Title: The Potential of the Transformative Dyadic C1 Protein Technology in Helping Meet Global Health ChallengesTime: Tuesday, May 4, 2021 10:00 AM Eastern Time The conversation will be moderated by Dr. David Bramhill, a veteran in the biotechnology industry with extensive experience using a wide array of protein production technologies. The...

Continue reading

Chuy’s Holdings, Inc. Appoints Jody Bilney to Board of Directors

AUSTIN, Texas, May 03, 2021 (GLOBE NEWSWIRE) — Chuy’s Holdings, Inc. (NASDAQ:CHUY) (“Chuy’s” or the “Company”) today announced that Jody Bilney has been appointed as an independent member of its Board of Directors. With her appointment, the Board will be comprised of seven members, five of whom are independent. Steve Hislop, Chairman, President and Chief Executive Officer of Chuy’s, stated, “We are thrilled to welcome Jody to the Board. Her experience leading marketing and business strategy for consumer-focused, category-leading brands will not only add to our Board’s depth of expertise, but will also be integral in differentiating the guest experience at Chuy’s.” Jody Bilney commented, “I’ve long considered Chuy’s to be one of the most unique brands in the restaurant industry with its made-from-scratch food and drink offerings...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.